Skip to main content
Equibles
HCA logo

HCA · HCA Healthcare, Inc.

Track HCA — free

Use HCA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HCA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$426.60 -0.14 (-0.03%)
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$96.64B
Shares
221.84M
Volume · Sep 30 1.24M Avg daily vol (3M) 1.5M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$426.74 Open$430.25 Day$425.96–434.07 52W close$361.32–545.13 Avg vol 30d1.4M Short int6.5M · 2.9% float · 4.5d Short vol53% Last earningsJul 24, 2026 DataJan 2020–Sep 2026 Filing10-Q · Jul 28

Up next

Next earnings call
Oct 23, 2026 Est · unconfirmed · in 3 wks
Latest filing: 10-Q
filed Jul 28, 2026
Q2 2026 earnings call transcript
call held Jul 24, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$76.39B
Trailing 12 months
Net income (TTM)
$6.79B
Trailing 12 months
Revenue growth YoY
+4.3%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
14.9
Trailing earnings · reciprocal yield 6.7%
FCF yield
8.2%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$47.08B
Latest balance sheet
Dividend yield
0.7%
Trailing 12 months
Shares change YoY
-9.1%
Year over year · fewer shares
Price change (1Y)
+2.5%
Trailing year
Short interest
2.9%
Latest settlement · 4.5 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Weak Sentiment Bearish Fundamentals Excellent Quant / Vol Moderate
Market backdrop VIX 16.3 · calm Equity put/call 0.53
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −4%
below
Price vs 50-day avg +3%
above
RSI (14) 52
neutral
MACD trend Negative
52-week position 36%
mid-range
Volume (OBV) Bearish div.
distributing
Momentum
relative strength
Weak
1-month return +3%
trailing
6-month return −16%
trailing
YTD return −9%
this year
Relative strength −28%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $415 › 200d $447 — 200d above 50d
Institutional flow Distributing
-6% holders QoQ · +121 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
2.92% of float · ▲ +5.6% MoM · 4.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
1,351 holders — mid 3-yr range
Squeeze score 68
elevated · 0–100
Fundamentals
Excellent
Revenue growth +7%
Y/Y
EPS growth +29%
Y/Y
Free cash flow $7.7B
Valuation P/E 15
in line
Buyback $7.2B
remaining
Balance sheet $516.0M
net cash
Quant / Vol
risk profile
Moderate
Volatility 31%
annualized · 1-yr
Max drawdown −34%
past year
ATR 2.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 6 of last 6
Latest guidance · from the 8-K filed Jul 24, 2026
Revenues · 2026 $77B – $79.5B
prior FY $75.6B midpoint +3.5% Y/Y
Net Income Attributable to HCA Healthcare, Inc. · 2026 $6.3B – $6.7B
Adjusted EBITDA · 2026 Non-GAAP $15.4B – $16.1B
EPS (diluted) · 2026 $28.70 – $30.50
prior FY $28.33 midpoint +4.5% Y/Y
Capital expenditures, excluding acquisitions · 2026 $5B – $5.5B
Incremental net benefit from Medicaid Supplemental Payment Progr · 2026 $300M – $500M
Guided vs delivered · last 6 settled
EPS (diluted) For the Year Ending December 31, 2024
guided $21.60 – $22.80
$22.00 In line
Revenues 2024
guided $67.75B – $70.25B
$70.6B Beat +2.3%
Revenues 2023
guided $63.5B – $64.5B
$64.97B Beat +1.5%
EPS (diluted) 2023
guided $17.80 – $18.50
$18.97 Beat +4.5%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
2 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−4% Neutral
Price vs 50-day avg
+3% Bullish
RSI (14)
52 Neutral
MACD trend
Negative Bearish
52-week position
36% Neutral
Volume (OBV)
Bearish div. Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $415 › 200d $447 — 200d above 50d
Institutional flow Distributing
-6% holders QoQ · +121 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
2.92% of float · ▲ +5.6% MoM · 4.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
1,351 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $361 Now $427 · 36% Range high $545
vs 200-day avg -4% vs 50-day avg +3%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Medical Care Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
HCA
HCA Healthcare, Inc.
this stock
$96.64B -8.6% +7.1% 15.0 2.9%
FSNUY
Fresenius SE & Co. KGaA
 $29.92B -11.6% — — 0.0%
THC
Tenet Healthcare Corp
 $20.91B +28.6% +0.9% 10.0 2.5%
EHC
Encompass Health Corp
 $12.18B +14.5% +10.5% 20.1 3.0%
FMS
Fresenius Medical Care AG
 $12.08B -6.0% +5.9% — 0.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
1,351
% held
60.1%
Net QoQ
+66.4K sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
892
View
Short & Settlement
Short Interest Rising
Shares short
6.5M
Days to cover
4.5d
Change
+344.4K sh
View
Short Volume
Short vol %
53%
As of
Sep 30, 2026
Short Total
View
Fails to Deliver
FTD shares
104.6K
Value
$44.8M
As of
Aug 26, 2026
View
Off-Exchange
Off-exchange %
38.1%
Week of
Aug 24, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Buy
Member
Jared Moskowitz
Amount
$1.0K–$15.0K
Traded
Jun 17, 2026
View
Financials
Financials
Revenue (FY)
$75.6B
Net income (FY)
$6.8B
EPS diluted
$28.33
View
Buybacks
Authorized
$10.0B
Remaining
$7.2B
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Jul 29, 2026
This year
15
View
Proposed Sales
Value
$903.5K
Shares
1.7K
Filed
Feb 18, 2026
View
Earnings & Events
Earnings Calls
Last call
Jul 24, 2026
View
Investor Relations
Latest news
HCA Healthcare Reports Second Qua…
Published
Jul 24, 2026
View

Performance

5D 20D 120D MTD YTD
HCA -2.2% +3.2% -15.9% +3.0% -8.6%
SPY -0.7% +0.1% +12.2% -0.6% +11.8%
vs SPY -1.6% +3.1% -28.0% +3.6% -20.4%

Capital returns

Latest dividend
$0.78 / share · ex Sep 16, 2026
Raised 8.3%
Paid (TTM)
$3.06 / share · 4 payouts
Dividend yield (TTM, derived)
0.72%
Buyback program · as of Jun 30, 2026
Authorized
$10.00B
Spent (derived)
$2.79B
Remaining
$7.21B
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 860730 CUSIP 40412C101 13F (30d) 25 filings 18 filers Visit website Investor relations